Healthcare provider profile · identity verified

William Jeffrey Davis, DO

Family Practice · STEWARTSTOWN, PA · NPI 1275506651

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	520	161
Lisinopril	Lisinopril	416	125
Levothyroxine Sodium	Levothyroxine Sodium	331	98
Amlodipine Besylate	Amlodipine Besylate	256	83
Rosuvastatin Calcium	Rosuvastatin Calcium	253	79
Metoprolol Succinate	Metoprolol Succinate	226	73
Pantoprazole Sodium	Pantoprazole Sodium	210	61
Omeprazole	Omeprazole	207	60
Prednisone	Prednisone	207	131
Tamsulosin Hcl	Tamsulosin Hcl	183	55
Metformin Hcl Er	Metformin Hcl	169	49
Gabapentin	Gabapentin	153	51
Hydrochlorothiazide	Hydrochlorothiazide	141	42
Simvastatin	Simvastatin	138	41
Albuterol Sulfate Hfa	Albuterol Sulfate	134	51
Furosemide	Furosemide	134	49
Trazodone Hcl	Trazodone Hcl	134	40
Metoprolol Tartrate	Metoprolol Tartrate	130	38
Cephalexin	Cephalexin	121	98
Azithromycin	Azithromycin	111	77
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	109	33
Sertraline Hcl	Sertraline Hcl	104	32
Diclofenac Sodium	Diclofenac Sodium	103	25
Carvedilol	Carvedilol	100	29
Allopurinol	Allopurinol	98	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	96	33
Eliquis	Apixaban	94	29
Potassium Chloride	Potassium Chloride	89	25
Pravastatin Sodium	Pravastatin Sodium	89	23
Atenolol	Atenolol	88	22
Glipizide	Glipizide	85	25
Losartan Potassium	Losartan Potassium	84	30
Metformin Hcl	Metformin Hcl	83	25
Methylprednisolone	Methylprednisolone	80	75
Alprazolam	Alprazolam	70	18
Famotidine	Famotidine	70	22
Clopidogrel	Clopidogrel Bisulfate	69	26
Lorazepam	Lorazepam	69	13
Meloxicam	Meloxicam	66	26
Escitalopram Oxalate	Escitalopram Oxalate	62	20
Hydralazine Hcl	Hydralazine Hcl	62	23
Pioglitazone Hcl	Pioglitazone Hcl	59	18
Oxybutynin Chloride	Oxybutynin Chloride	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	50	16
Alendronate Sodium	Alendronate Sodium	49	22
Fluticasone Propionate	Fluticasone Propionate	48	18
Ozempic	Semaglutide	46	17
Montelukast Sodium	Montelukast Sodium	45	17
Amitriptyline Hcl	Amitriptyline Hcl	43	18
Ezetimibe	Ezetimibe	41	16
Fenofibrate	Fenofibrate	41	14
Nifedipine Er	Nifedipine	41	15
Warfarin Sodium	Warfarin Sodium	41	suppressed
Valacyclovir	Valacyclovir Hcl	38	15
Ibuprofen	Ibuprofen	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	12
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Celecoxib	Celecoxib	33	suppressed
Buspirone Hcl	Buspirone Hcl	31	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	11
Januvia	Sitagliptin Phosphate	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	11
Glimepiride	Glimepiride	28	suppressed
Ondansetron Odt	Ondansetron	28	12
Amoxicillin	Amoxicillin	27	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Levofloxacin	Levofloxacin	27	16
Baclofen	Baclofen	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	21
Fluconazole	Fluconazole	25	12
Meclizine Hcl	Meclizine Hcl	25	suppressed
Colchicine	Colchicine	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	14
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Valsartan	Valsartan	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Finasteride	Finasteride	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Pregabalin	Pregabalin	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Brilinta	Ticagrelor	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Flecainide Acetate	Flecainide Acetate	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Naproxen	Naproxen	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Ramipril	Ramipril	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error